Preferential Effect of Synchrotron Microbeam Radiation Therapy on Intracerebral 9L Gliosarcoma Vascular Networks, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.5, pp.1503-1512, 2010. ,
DOI : 10.1016/j.ijrobp.2010.06.021
URL : https://hal.archives-ouvertes.fr/hal-00556537
Antimitotic and Antiproliferative Activities of Chalcones: Forward Structure???Activity Relationship, Journal of Medicinal Chemistry, vol.51, issue.7, pp.2307-2310, 2008. ,
DOI : 10.1021/jm0708331
A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivoglioblastoma models, BMC Cancer, vol.6, issue.7, p.242, 2009. ,
DOI : 10.1158/1535-7163.MCT-07-0047
New technology enables high precision multislit collimators for microbeam radiation therapy, Review of Scientific Instruments, vol.80, issue.7, p.74301, 2009. ,
DOI : 10.1063/1.3170035
Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissue, Mutation Research/Reviews in Mutation Research, vol.704, issue.1-3, pp.160-166, 2009. ,
DOI : 10.1016/j.mrrev.2009.12.003
A method of dosimetry for synchrotron microbeam radiation therapy using radiochromic films of different sensitivity, Physics in Medicine and Biology, vol.53, issue.23, pp.6861-6877, 2008. ,
DOI : 10.1088/0031-9155/53/23/014
Antioxidant and Chemosensitizing Effects of Flavonoids with Hydroxy and/or Methoxy Groups and Structure-Activity Relationship, Journal of Pharmacy & Pharmaceutical Sciences, vol.10, issue.4, pp.537-546, 2007. ,
DOI : 10.18433/J3KW2Z
Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain, International Journal of Radiation Oncology*Biology*Physics, vol.47, issue.2, pp.511-516, 2000. ,
DOI : 10.1016/S0360-3016(00)00428-4
Fractionated radiosurgery for 9L gliosarcoma in the rat brain, International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.4, pp.1035-1040, 1999. ,
DOI : 10.1016/S0360-3016(99)00273-4
Neuropathology of ablation of rat gliosarcomas and contiguous brain tissues using a microplanar beam of synchrotron-wiggler-generated X rays, International Journal of Cancer, vol.14, issue.5, pp.654-660, 1998. ,
DOI : 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L
Endoreplication: polyploidy with purpose, Genes & Development, vol.23, issue.21, pp.2461-2477, 2009. ,
DOI : 10.1101/gad.1829209
Antitumor Agents. 280. Multidrug Resistance-Selective Desmosdumotin B Analogues, Journal of Medicinal Chemistry, vol.53, issue.18, pp.6699-6705, 2010. ,
DOI : 10.1021/jm100846r
pink-beam imaging and fast alignment procedure for rat brain lesion microbeam radiation therapy, Journal of Synchrotron Radiation, vol.64, issue.3, pp.325-331, 2010. ,
DOI : 10.1107/S0909049510006667
Synchrotron microbeam radiation therapy for rat brain tumor palliation???influence of the microbeam width at constant valley dose, Physics in Medicine and Biology, vol.54, issue.21, pp.6711-6724, 2009. ,
DOI : 10.1088/0031-9155/54/21/017
URL : https://hal.archives-ouvertes.fr/hal-00426057
First trial of spatial and temporal fractionations of the delivered dose using synchrotron microbeam radiation therapy, Journal of Synchrotron Radiation, vol.16, issue.4, pp.587-590, 2009. ,
DOI : 10.1107/S0909049509012485
URL : https://hal.archives-ouvertes.fr/hal-00421096
High-Precision Radiosurgical Dose Delivery by Interlaced Microbeam Arrays of High-Flux Low-Energy Synchrotron X-Rays, PLoS ONE, vol.5, issue.2, p.9028, 2010. ,
DOI : 10.1371/journal.pone.0009028.t001
URL : https://hal.archives-ouvertes.fr/hal-00456405
study, Physics in Medicine and Biology, vol.53, issue.13, pp.3609-3622, 2008. ,
DOI : 10.1088/0031-9155/53/13/015
URL : https://hal.archives-ouvertes.fr/inserm-00381397
Synergy of gene-mediated immunoprophylaxis and microbeam radiation therapy for advanced intracerebral rat 9L gliosarcomas, Journal of Neuro-Oncology, vol.64, issue.064303, pp.135-143, 2006. ,
DOI : 10.1007/s11060-005-9094-9
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005. ,
DOI : 10.1056/NEJMoa043330
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma, Clinical Cancer Research, vol.13, issue.4, pp.1253-1259, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-2309
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme, Journal of Clinical Oncology, vol.25, issue.30, pp.4722-4729, 2007. ,
DOI : 10.1200/JCO.2007.12.2440